The proteins that cover nanoparticles are essential to understanding how they work in the body. Across 17 proteomics facilities in the US, less than 2% of the identified proteins were identical.
The FDA has chosen not to regulate lab-developed tests like the ones at the center of the Theranos trial.
A new test, which can diagnose COVID-19 in 15 minutes, has been approved by the TGA. But it’s no silver bullet.
Ideally everyone could get tested frequently for the coronavirus. No state is close to achieving this, but some are doing better than others. What are the challenges in meeting demand for testing?
Practical work is essential for science education. But health measures compromise their traditional organization. Here are some game-changing solutions.
Concerned about rising cases and spread of Lassa fever, the Nigerian Academy of Science has called on government to declare it a national health emergency.
Considerable effort has gone into improving laboratory services in many African countries. But the quality of tests is questionable.